Given PolyPeptide's exposure to high-growth end-markets, Barclays concludes that the company's prospects are improving. This article was generated with the support of AI and reviewed by an editor ...

The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud has ...